Completed
Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors
NCT01392547
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Clinical Trial Call Center Tucson, Arizona, United States
- Novo Nordisk Clinical Trial Call Center Los Angeles, California, United States
- Novo Nordisk Clinical Trial Call Center Los Angeles, California, United States
- Novo Nordisk Clinical Trial Call Center Orange, California, United States